X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs SANOFI INDIA - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD SANOFI INDIA WYETH LTD/
SANOFI INDIA
 
P/E (TTM) x 27.7 32.8 84.4% View Chart
P/BV x 5.3 6.3 85.5% View Chart
Dividend Yield % 1.3 1.4 88.3%  

Financials

 WYETH LTD   SANOFI INDIA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
SANOFI INDIA
Dec-16
WYETH LTD/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs1,0444,560 22.9%   
Low Rs8184,400 18.6%   
Sales per share (Unadj.) Rs298.61,028.5 29.0%  
Earnings per share (Unadj.) Rs57.2129.0 44.4%  
Cash flow per share (Unadj.) Rs58.4186.0 31.4%  
Dividends per share (Unadj.) Rs17.0068.00 25.0%  
Dividend yield (eoy) %1.81.5 120.3%  
Book value per share (Unadj.) Rs249.5753.6 33.1%  
Shares outstanding (eoy) m22.7223.03 98.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.14.4 71.6%   
Avg P/E ratio x16.334.7 46.8%  
P/CF ratio (eoy) x15.924.1 66.2%  
Price / Book Value ratio x3.75.9 62.8%  
Dividend payout %29.752.7 56.3%   
Avg Mkt Cap Rs m21,157103,174 20.5%   
No. of employees `0000.53.6 13.6%   
Total wages/salary Rs m4003,592 11.1%   
Avg. sales/employee Rs Th13,787.46,537.7 210.9%   
Avg. wages/employee Rs Th813.0991.4 82.0%   
Avg. net profit/employee Rs Th2,643.3819.8 322.4%   
INCOME DATA
Net Sales Rs m6,78323,686 28.6%  
Other income Rs m353708 49.8%   
Total revenues Rs m7,13624,394 29.3%   
Gross profit Rs m1,6175,281 30.6%  
Depreciation Rs m271,313 2.0%   
Interest Rs m615 36.7%   
Profit before tax Rs m1,9384,661 41.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6321,691 37.4%   
Profit after tax Rs m1,3012,970 43.8%  
Gross profit margin %23.822.3 106.9%  
Effective tax rate %32.636.3 89.9%   
Net profit margin %19.212.5 152.9%  
BALANCE SHEET DATA
Current assets Rs m6,98415,673 44.6%   
Current liabilities Rs m2,0566,678 30.8%   
Net working cap to sales %72.638.0 191.3%  
Current ratio x3.42.3 144.7%  
Inventory Days Days9976 130.6%  
Debtors Days Days2422 107.3%  
Net fixed assets Rs m2448,098 3.0%   
Share capital Rs m227230 98.7%   
"Free" reserves Rs m5,44117,088 31.8%   
Net worth Rs m5,66817,356 32.7%   
Long term debt Rs m250-   
Total assets Rs m7,90125,400 31.1%  
Interest coverage x353.3311.7 113.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.9 92.1%   
Return on assets %16.511.8 140.7%  
Return on equity %22.917.1 134.1%  
Return on capital %34.026.9 126.4%  
Exports to sales %0.224.5 0.9%   
Imports to sales %36.328.0 129.9%   
Exports (fob) Rs m155,801 0.3%   
Imports (cif) Rs m2,4656,627 37.2%   
Fx inflow Rs m157,145 0.2%   
Fx outflow Rs m2,6776,846 39.1%   
Net fx Rs m-2,662299 -890.3%   
CASH FLOW
From Operations Rs m9233,226 28.6%  
From Investments Rs m317-1,555 -20.4%  
From Financial Activity Rs m-481-1,818 26.5%  
Net Cashflow Rs m759-147 -516.4%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.1 60.4 84.6%  
Indian inst/Mut Fund % 11.3 14.4 78.5%  
FIIs % 7.2 14.6 49.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 10.5 289.5%  
Shareholders   21,978 15,184 144.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   SHASUN PHARMA  CIPLA  TORRENT PHARMA  UNICHEM LAB  DR. REDDYS LAB  

Compare WYETH LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Breaches 36,000 Mark; ONGC Nears 52-Week High(Closing)

The NSE Nifty on Tuesday sailed past the 11,000 mark, while the BSE Sensex breached the 36,000 level for the first time after an IMF report showed India was set to regain.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD 8-QTR ANALYSIS

COMPARE WYETH LTD WITH

MARKET STATS